139 related articles for article (PubMed ID: 15330982)
1. Experimental Burkholderia pseudomallei infection of pigs.
Najdenski H; Kussovski V; Vesselinova A
J Vet Med B Infect Dis Vet Public Health; 2004 Jun; 51(5):225-30. PubMed ID: 15330982
[TBL] [Abstract][Full Text] [Related]
2. Clinical variation in melioidosis in pigs with clonal infection following possible environmental contamination from bore water.
Millan JM; Mayo M; Gal D; Janmaat A; Currie BJ
Vet J; 2007 Jul; 174(1):200-2. PubMed ID: 16807011
[TBL] [Abstract][Full Text] [Related]
3. CD14 impairs host defense against gram-negative sepsis caused by Burkholderia pseudomallei in mice.
Wiersinga WJ; de Vos AF; Wieland CW; Leendertse M; Roelofs JJ; van der Poll T
J Infect Dis; 2008 Nov; 198(9):1388-97. PubMed ID: 18855560
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2).
Barnes JL; Williams NL; Ketheesan N
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):379-88. PubMed ID: 18294191
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice.
West TE; Myers ND; Limmathurotsakul D; Liggitt HD; Chantratita N; Peacock SJ; Skerrett SJ
Am J Trop Med Hyg; 2010 Nov; 83(5):1066-9. PubMed ID: 21036839
[TBL] [Abstract][Full Text] [Related]
6. [The interaction of the causative agent of melioidosis with the host's alveolar macrophages].
Popov SF; Kurilov VIa; Lagutin MP
Mikrobiol Zh (1978); 1992; 54(4):3-7. PubMed ID: 1383676
[TBL] [Abstract][Full Text] [Related]
7. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation.
Taweechaisupapong S; Kaewpa C; Arunyanart C; Kanla P; Homchampa P; Sirisinha S; Proungvitaya T; Wongratanacheewin S
Microb Pathog; 2005 Sep; 39(3):77-85. PubMed ID: 16084684
[TBL] [Abstract][Full Text] [Related]
8. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei.
Easton A; Haque A; Chu K; Lukaszewski R; Bancroft GJ
J Infect Dis; 2007 Jan; 195(1):99-107. PubMed ID: 17152013
[TBL] [Abstract][Full Text] [Related]
9. Porcine toxoplasmosis in Indiana.
Dubey JP; Weisbrode SE; Sharma SP; Al-Khalidi NW; Zimmerman JL; Gaafar SM
J Am Vet Med Assoc; 1979 Mar; 174(6):604-9. PubMed ID: 422464
[TBL] [Abstract][Full Text] [Related]
10. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
11. Larval distribution and histopathology of experimental Strongyloides ransomi infection in young swine.
Stone WM; Simpson CF
Can J Comp Med Vet Sci; 1967 Aug; 31(8):197-202. PubMed ID: 4227912
[TBL] [Abstract][Full Text] [Related]
12. Inflammation patterns induced by different Burkholderia species in mice.
Wiersinga WJ; de Vos AF; de Beer R; Wieland CW; Roelofs JJ; Woods DE; van der Poll T
Cell Microbiol; 2008 Jan; 10(1):81-7. PubMed ID: 17645551
[TBL] [Abstract][Full Text] [Related]
13. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics.
Lee SH; Chong CE; Lim BS; Chai SJ; Sam KK; Mohamed R; Nathan S
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):263-70. PubMed ID: 17350202
[TBL] [Abstract][Full Text] [Related]
14. A role of Burkholderia pseudomallei flagella as a virulent factor.
Chuaygud T; Tungpradabkul S; Sirisinha S; Chua KL; Utaisincharoen P
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S140-4. PubMed ID: 19121676
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole.
Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE
J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684
[TBL] [Abstract][Full Text] [Related]
16. Comparison by electron microscopy of intracellular events and survival of Burkholderia pseudomallei in monocytes from normal subjects and patients with melioidosis.
Puthucheary SD; Nathan SA
Singapore Med J; 2006 Aug; 47(8):697-703. PubMed ID: 16865211
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellin.
Chen YS; Hsiao YS; Lin HH; Yen CM; Chen SC; Chen YL
Vaccine; 2006 Feb; 24(6):750-8. PubMed ID: 16169637
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lesion formation in marmosets following inhalational challenge with different strains of Burkholderia pseudomallei.
Nelson M; Nunez A; Ngugi SA; Sinclair A; Atkins TP
Int J Exp Pathol; 2015 Dec; 96(6):414-26. PubMed ID: 26852689
[TBL] [Abstract][Full Text] [Related]
19. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
Warawa J; Woods DE
FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
[TBL] [Abstract][Full Text] [Related]
20. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis.
Cuccui J; Easton A; Chu KK; Bancroft GJ; Oyston PC; Titball RW; Wren BW
Infect Immun; 2007 Mar; 75(3):1186-95. PubMed ID: 17189432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
